- Home
- CELU vs NPT Comparison
CELU vs NPT Comparison
Compare CELU & NPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELU | NPT |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | China |
| Employees | 123 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.2M | 39.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CELU | NPT |
|---|---|---|
| Price | $0.86 | $1.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 112.8K | ★ 313.9K |
| Earning Date | 05-11-2026 | 05-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $76.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | $1.14 |
| 52 Week High | $4.35 | $22.38 |
Technical Indicators
Market Signals| Indicator | CELU | NPT |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 36.11 |
| Support Level | $0.71 | $1.19 |
| Resistance Level | $1.44 | $1.69 |
| Average True Range (ATR) | 0.06 | 0.16 |
| MACD | 0.02 | 0.26 |
| Stochastic Oscillator | 64.72 | 39.29 |
Price Performance
Historical ComparisonAbout CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.